Back to CAPTRUST FINANCIAL ADVISORS CAPTRUST FINANCIAL ADVISORS

CBAYCBAY
12 quarters

Position history for CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS's holdings in CYMABAY THERAPEUTICS INC

As of its Q4 2023 13F, Captrust held 30,973 shares of CBAY (Cymabay Therapeutics), worth $731,582. Captrust's 13F filings listed CBAY from Q3 2023 to Q4 2023, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$25,000

Total Shares Change

-3,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
Decreased
30,973
-31.9%
$731,5820.0%—
0
2023-Q3
New
45,509
-
$678,5390.0%—
34
2022-Q3
Exited
0
-100.0%
$00.0%—
0
2022-Q2
Decreased
5,628
-22.4%
$17,0000.0%—
0
2022-Q1
Unchanged
7,256
0.0%
$23,0000.0%—
0
2021-Q4
Increased
7,256
+20.6%
$25,0000.0%—
23
2021-Q3
Unchanged
6,015
0.0%
$22,0000.0%—
0
2021-Q2
Unchanged
6,015
0.0%
$26,0000.0%—
0
2021-Q1
Increased
6,015
+71.9%
$27,0000.0%—
29
2020-Q4
Unchanged
3,500
0.0%
$20,0000.0%—
0
2020-Q3
New
3,500
-
$25,0000.0%—
27

Other major holders of CBAY: Avoro Capital Advisors LLC, BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used